那不勒斯预后评分对小细胞肺癌患者的预后价值  

Prognostic value of the Naples prognostic score in patients with small cell lung cancer

作　　者：钟宇卓 张文玲 何杰 李静[1] 雷震[1] ZHONG Yuzhuo;ZHANG Wenling;HE Jie;LI Jing;LEI Zhen(Department of Respiratory and Critical Care Medicine,Affiliated Hospital of Sichuan North Medical College,Nanchong 637000,China)

机构地区：[1]川北医学院附属医院呼吸与危重症医学科,四川南充637000

出　　处：《现代医学》2025年第4期639-646,共8页Modern Medical Journal

摘　　要：目的:探讨那不勒斯预后评分(NPS)对小细胞肺癌(SCLC)患者的预后价值。方法:回顾性分析2017年1月至2022年1月收治的206例SCLC患者的临床资料。根据NPS将患者分为低危组(NPS=0分)、中危组(NPS=1~2分)和高危组(NPS=3~4分),对3组患者的临床资料进行比较与分析。绘制受试者工作特征(ROC)曲线并计算曲线下面积(AUC),比较NPS与预后营养指数(PNI)、血小板/淋巴细胞比值(PLR)对生存预后的价值。利用Cox回归分析和Kaplan-Meier(K-M)曲线分析患者的生存数据,比较NPS对无进展生存期(PFS)和总生存期(OS)的影响。结果:根据治疗前NPS结果,低危组纳入35例患者,中危组纳入92例患者,高危组纳入79例患者。ROC曲线表明,NPS在预后方面优于其他炎症评分(AUC=0.726)。K-M曲线显示,NPS与小细胞肺癌(SCLC)患者的无进展生存期(PFS)和总生存期(OS)之间存在显著相关性(P<0.001),高危组SCLC患者预后更差(P<0.001)。结论:那不勒斯预后评分(NPS)在小细胞肺癌(SCLC)患者的预后中有较好的预测价值,该评分的预测价值优于其他营养及炎症指标,NPS高危组的患者预后相对较差。Objective:To investigate the prognostic value of Naples prognostic score(NPS)in patients with small cell lung cancer(SCLC).Methods:The clinical data of 206 patients with SCLC admitted from January 2017 to January 2022 were retrospectively analyzed.Based on the NPS,the patients were divided into low-risk group(NPS=0 point),intermediate-risk group(NPS=1-2 points)and high-risk group(NPS=3-4 points).The clinical date of the three groups were compared.Receiver operating characteristic(ROC)curves were plotted,and the area under the curve(AUC)was calculated to compare the prognostic value of NPS with that of the prognostic nutritional index(PNI)and platelet-to-lymphocyte ratio(PLR)for survival outcomes.Cox regression analysis and Kaplan-Meier(K-M)curves were used to analyze patient survival data and compare the effect of NPS on progression-free survival(PFS)and overall survival(OS).Results:According to the NPS results of pretreatment,35 patients were categorized in low-risk group,92 patients in intermediate-risk group,and 79 patients in high-risk group.The ROC curves showed that NPS was superior to other inflammatory scores in terms of prognosis(AUC=0.726).The K-M curves demonstrated a significant correlation between the NPS and both PFS and OS in patients with SCLC(P<0.001).Patients in the high-risk group had a worse prognosis compared to other groups(P<0.001).Conclusion:The NPS shows significant predictive value for the prognosis of patients with SCLC,outperforming other nutritional and inflammatory indicators.Patients in the high-risk NPS group have a relatively poorer prognosis.

关 键 词：小细胞肺癌 那不勒斯预后评分 预后 总生存期 无进展生存期 

分 类 号：R734.2[医药卫生—肿瘤]